Search: onr:"swepub:oai:lup.lub.lu.se:af43be75-580c-49d4-89e8-57e5156f00a2" >
Neurokinins and the...
Neurokinins and their receptors in the rat trigeminal system : Differential localization and release with implications for migraine pain
-
- Edvinsson, Jacob C.A. (author)
- University of Copenhagen,Copenhagen University Hospital
-
- Reducha, Philip V. (author)
- Copenhagen University Hospital,University of Copenhagen
-
- Sheykhzade, Majid (author)
- University of Copenhagen
-
show more...
-
- Warfvinge, Karin (author)
- Lund University,Lunds universitet,Medicin/akutsjukvård, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Copenhagen University Hospital
-
- Haanes, Kristian A. (author)
- University of Copenhagen,Copenhagen University Hospital
-
- Edvinsson, Lars (author)
- Lund University,Lunds universitet,Medicin/akutsjukvård, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Experimentell kärlforskning,Forskargrupper vid Lunds universitet,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Experimental Vascular Research,Lund University Research Groups,Copenhagen University Hospital
-
show less...
-
(creator_code:org_t)
- 2021-12-13
- 2021
- English.
-
In: Molecular Pain. - : SAGE Publications. - 1744-8069. ; 17
- Related links:
-
http://dx.doi.org/10... (free)
-
show more...
-
https://journals.sag...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Substance P (SP) and calcitonin gene-related peptide (CGRP) have both been considered potential drug candidates in migraine therapy. In recent years, CGRP receptor inhibition has been established as an effective treatment, in particular as a prophylactic for chronic migraine. Curiously, inhibition of neurokinin receptor 1 (NK1R) failed to alleviate acute migraine attacks in clinical trials, and the neurokinins were consequently abandoned as potential antimigraine candidates. The reason behind this has remained enigmatic. Utilizing immunohistochemistry and semi-quantitative cell counts the expression of neurokinins and their associated receptors was examined in the rat trigeminal ganglion. Immunohistochemistry results revealed SP co-localization in CGRP positive neurons and C-fibres, where it mainly concentrated at boutons. Neurokinin A (NKA) was observed in a population of C-fibres and small neurons where it could co-localize with SP. In contrast, neurokinin B (NKB) did not co-localize with SP and was observed in large/medium sized neurons and Aδ-fibres. All neurokinin receptors (NK1-3R) were found to be expressed in a majority of trigeminal ganglion neurons and A-fibres. The functional release of SP and CGRP in the trigeminovascular system was stimulated with either 60 mM K+ or 100 nM capsaicin and measured with an enzyme-linked immunosorbent assay (ELISA). ELISA results established that SP can be released locally from trigeminovascular system. The released SP was comparatively minor compared to the CGRP release from stimulated dura mater, trigeminal ganglion neurons and fibres. We hypothesize that SP and CGRP signalling pathways may work in tandem to exacerbate painful stimuli in the TGV system.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Keyword
- CGRP
- migraine
- neurokinin
- Substance P
- trigeminal system
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database